Visualitzant tema Sanitari Integral d'Utilització Pública de Catalunya

Obeid-Coronal Malalignment Classification Is Age Related and Independently Associated to Personal Reported Outcome Measurement Scores in the Nonfused Spine

Kieser, David Christopher; Hayashi, Kazunori; Cawley, Derek; Yilgor, Caglar; Pellisé Uriquiza, Ferran; Bourghli, Anouar; Boissiere, Louis (Korean Spinal Neurosurgery Society, 2021-09)

Obesity and Breast Cancer: A Paradoxical and Controversial Relationship Influenced by Menopausal Status

García-Estévez, Laura; Cortés Castan, Javier; Pérez, Silvia; Calvo, Isabel; Gallegos, Isabel; Moreno-Bueno, Gema (Frontiers Media, 2021-08-13)

Obesity and related comorbidities in a large population-based cohort of subjects with type 1 diabetes in Catalonia

Genua, Idoia; Navas, Elena; Mauricio-Puente, Dídac; Goday Arno, Albert Albert; Franch-Nadal, Josep; Mata-Cases, Manel; Gimenez-Perez, Gabriel; Vlacho, Bogdan (Frontiers Media, 2022-12-02)

Obesity Weight Loss Phenotypes in CKD: Measured GFR and Albumin-to-Creatinine Excretion Ratio Place for Stratification

Fontalvo Montoya, Edwin; Machado, Miriam; Lopez Martinez, Marina; Soler, María José (Elsevier, 2023-11)

Obès metabòlicament sa, mite o realitat?

Pellitero, Silvia (Institut Català de la Salut, 2016-06-03)

Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study

Bosch Albareda, Francesc; Cantin, Guy; Cortelezzi, Agostino; Knauf, Wolfgang; Tiab, Mourad; Turgut, Mehmet (Springer Nature, 2020-02)

Observación en urgencias previa a la hospitalización en pacientes con insuficiencia cardiaca aguda: impacto sobre el pronóstico a corto plazo

López Díez, María Pilar; Llorens, Pere; Martín-Sánchez, Francisco Javier; Gil, Víctor; Jacob, Javier; Herrero, Pablo; Tost, Josep (Emergencias, 2022-10)

Observational study of HR+/HER2− metastatic breast cancer patients treated with abemaciclib in Spain in the Named Patient Use Program (AbemusS)

Blanch, Salvador; Gil Gil, Miguel J.; Arumí De Dios, Míriam; SEGUI PALMER, MIQUEL ANGEL; Atienza, Manuel; AGUIRRE, ELENA (Springer, 2023-10)

Observational study on fluid therapy management in surgical adult patients

Colomina, Maria Jose; Ripollés‑Melchor, Javier; Guilabert Sanz, Patricia; Jover Pinillos, Jose Luis; Basora, M.; Cassinello, Concepción (BMC, 2021-12-13)

Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women

Cruz-Lemini, Mónica; Ferriols Pérez, Elena; de la Cruz, María Luisa; Caño Aguilar, Africa; Encinas Pardilla, Maria Begoña; Prats, P; Rodríguez, Agueda (MDPI, 2021-01-15)

Occupational radiation exposure of electrophysiology staff with reproductive potential and during pregnancy: an EHRA survey

Adeliño, Raquel; Malaczynska-Rajpold, Katarzyna; Perrotta, Laura; Manninger, Martin; Vanduynhoven, Philippe; Nesti, Martina (Oxford University Press, 2023-08-02)

Ocrelizumab exposure in relapsing–remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension

Kappos, Ludwig; Li, David K B; Bar-Or, Amit; Barkhof, Frederik; Traboulsee, Anthony; Montalban, Xavier (Springer, 2024-02)

Off-Label Use of Rituximab in Patients with Different Types of Nephropathies in a Tertiary Hospital: A Retrospective Study

Sans Pola, Carla; Agustí Escasany, Maria Antònia; Bosch Gil, José Ángel; Agraz Pamplona, Irene; Alerany Pardo, Carme; Danes Carreras, Immaculada (MDPI, 2021-10-26)

Off-label use of rituximab in patients with systemic lupus erythematosus with extrarenal disease activity: a retrospective study and literature review

Sans-Pola, Carla; Danés Carreras, Immaculada; Bosch, Josep Àngel; Marrero Álvarez, Patricia; Cortes Hernandez, Josefina; Agustí, Antònia (Frontiers Media, 2023-05-25)

Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Ring, Alistair; Kilburn, Lucy; Pearson, Alex; Moretti, Laura; Afshari-Mehr, Angelica; Wardley, Andrew; Llop Guevara, Alba; Serra, Violeta (American Association for Cancer Research, 2023-12-01)

Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial

Fizazi, Karim; Saad, Fred; Mateo, Joaquin; de Bono, Johann S; Shore, Neal; Sandhu, Shahneen (American Society of Clinical Oncology, 2024-02-10)

Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)

Perez-Fidalgo, J. A.; Cortés, A.; Guerra, Eva; García, Y.; Iglesias, M.; Bohn Sarmiento, U.; Oaknin Benzaquen, Ana Mazaltob (Elsevier, 2021-08)

Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial

Mateo Valderrama, Joaquim; Porta, Nuria; Bianchini, Diletta; McGovern, Ursula; Elliott, Tony; Jones, Robert (Elsevier, 2020-01-01)

Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis

Poveda, Andres; Lheureux, S.; Cibula, David; Weberpals, J.; Oaknin Benzaquen, Ana Mazaltob; Colombo, Nicoletta; Lindemann, Kristina (Elsevier, 2022-03)

Old zoonotic agents and novel variants of tick-borne microorganisms from Benguela (Angola), July 2017

Palomar, Ana M.; Bocanegra García, Maria Cristina; Portillo, Aránzazu; Salvador Velez, Fernando M; Moreno, María Milagros; Oteo, José A.; Molina Romero, Israel (BMC, 2022-04-21)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Visualitzant Sistema Sanitari Integral d'Utilització Pública de Catalunya - SISCAT per títol

Obeid-Coronal Malalignment Classification Is Age Related and Independently Associated to Personal Reported Outcome Measurement Scores in the Nonfused Spine

Obesity and Breast Cancer: A Paradoxical and Controversial Relationship Influenced by Menopausal Status

Obesity and related comorbidities in a large population-based cohort of subjects with type 1 diabetes in Catalonia

Obesity Weight Loss Phenotypes in CKD: Measured GFR and Albumin-to-Creatinine Excretion Ratio Place for Stratification

Obès metabòlicament sa, mite o realitat?

Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study

Observación en urgencias previa a la hospitalización en pacientes con insuficiencia cardiaca aguda: impacto sobre el pronóstico a corto plazo

Observational study of HR+/HER2− metastatic breast cancer patients treated with abemaciclib in Spain in the Named Patient Use Program (AbemusS)

Observational study on fluid therapy management in surgical adult patients

Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women

Occupational radiation exposure of electrophysiology staff with reproductive potential and during pregnancy: an EHRA survey

Ocrelizumab exposure in relapsing–remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension

Off-Label Use of Rituximab in Patients with Different Types of Nephropathies in a Tertiary Hospital: A Retrospective Study

Off-label use of rituximab in patients with systemic lupus erythematosus with extrarenal disease activity: a retrospective study and literature review

Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial

Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)

Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial

Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis

Old zoonotic agents and novel variants of tick-borne microorganisms from Benguela (Angola), July 2017

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Visualitzant Sistema Sanitari Integral d'Utilització Pública de Catalunya - SISCAT per títol

Obeid-Coronal Malalignment Classification Is Age Related and Independently Associated to Personal Reported Outcome Measurement Scores in the Nonfused Spine ﻿

Obesity and Breast Cancer: A Paradoxical and Controversial Relationship Influenced by Menopausal Status ﻿

Obesity and related comorbidities in a large population-based cohort of subjects with type 1 diabetes in Catalonia ﻿

Obesity Weight Loss Phenotypes in CKD: Measured GFR and Albumin-to-Creatinine Excretion Ratio Place for Stratification ﻿

Obès metabòlicament sa, mite o realitat? ﻿

Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study ﻿

Observación en urgencias previa a la hospitalización en pacientes con insuficiencia cardiaca aguda: impacto sobre el pronóstico a corto plazo ﻿

Observational study of HR+/HER2− metastatic breast cancer patients treated with abemaciclib in Spain in the Named Patient Use Program (AbemusS) ﻿

Observational study on fluid therapy management in surgical adult patients ﻿

Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women ﻿

Occupational radiation exposure of electrophysiology staff with reproductive potential and during pregnancy: an EHRA survey ﻿

Ocrelizumab exposure in relapsing–remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension ﻿

Off-Label Use of Rituximab in Patients with Different Types of Nephropathies in a Tertiary Hospital: A Retrospective Study ﻿

Off-label use of rituximab in patients with systemic lupus erythematosus with extrarenal disease activity: a retrospective study and literature review ﻿

Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010) ﻿

Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial ﻿

Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study) ﻿

Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial ﻿

Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis ﻿

Old zoonotic agents and novel variants of tick-borne microorganisms from Benguela (Angola), July 2017 ﻿

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Obeid-Coronal Malalignment Classification Is Age Related and Independently Associated to Personal Reported Outcome Measurement Scores in the Nonfused Spine

Obesity and Breast Cancer: A Paradoxical and Controversial Relationship Influenced by Menopausal Status

Obesity and related comorbidities in a large population-based cohort of subjects with type 1 diabetes in Catalonia

Obesity Weight Loss Phenotypes in CKD: Measured GFR and Albumin-to-Creatinine Excretion Ratio Place for Stratification

Obès metabòlicament sa, mite o realitat?

Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study

Observación en urgencias previa a la hospitalización en pacientes con insuficiencia cardiaca aguda: impacto sobre el pronóstico a corto plazo

Observational study of HR+/HER2− metastatic breast cancer patients treated with abemaciclib in Spain in the Named Patient Use Program (AbemusS)

Observational study on fluid therapy management in surgical adult patients

Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women

Occupational radiation exposure of electrophysiology staff with reproductive potential and during pregnancy: an EHRA survey

Ocrelizumab exposure in relapsing–remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension

Off-Label Use of Rituximab in Patients with Different Types of Nephropathies in a Tertiary Hospital: A Retrospective Study

Off-label use of rituximab in patients with systemic lupus erythematosus with extrarenal disease activity: a retrospective study and literature review

Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial

Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)

Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial

Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis

Old zoonotic agents and novel variants of tick-borne microorganisms from Benguela (Angola), July 2017